2026-03-26 12:19:24
Geron Corporation Elects Two New Directors to Board
Expected Stock impact: Slightly Positive
On March 25, 2026, Geron Corporation announced the election of Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. This decision was made by the Board upon the recommendation of the Nominating and Corporate Governance Committee. Both directors will serve as Class III directors, with their terms expiring at the Company's 2026 Annual Meeting of Stockholders. In addition to their election, Ms. Andrews has been appointed to the Audit Committee of the Board. The company confirmed that there are no arrangements or understandings between the newly elected directors and any other person regarding their election. Both directors will receive compensation in line with the company's standard arrangements for non-employee directors, as outlined in the definitive proxy statement filed with the SEC on April 8, 2025. Furthermore, the company will enter into standard indemnification agreements with both directors, which will require the company to indemnify them for certain expenses incurred in connection with their service as directors. This move is seen as a strategic enhancement to the Board's capabilities, given the extensive experience both directors bring from their previous roles in the pharmaceutical and biotechnology sectors.
